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Abstract: Essential oils (EOs) from Citrus are the main by-product of Citrus-processing industries.
In addition to food/beverage and cosmetic applications, citrus EOs could also potentially be used
as an alternative to antibiotics in food-producing animals. A commercial citrus EO—Brazilian
Orange Terpenes (BOT)—was fractionated by vacuum fractional distillation to separate BOT into
various fractions: F1, F2, F3, and F4. Next, the chemical composition and biological activities of
BOT and its fractions were characterized. Results showed the three first fractions had a high relative
amount of limonene (≥10.86), even higher than the whole BOT. Conversely, F4 presented a larger
relative amount of BOT’s minor compounds (carvone, cis-carveol, trans-carveol, cis-p-Mentha-2,8-
dien-1-ol, and trans-p-Mentha-2,8-dien-1-ol) and a very low relative amount of limonene (0.08–0.13).
Antibacterial activity results showed F4 was the only fraction exhibiting this activity, which was
selective and higher activity on a pathogenic bacterium (E. coli) than on a beneficial bacterium
(Lactobacillus sp.). However, F4 activity was lower than BOT. Similarly, F4 displayed the highest
antioxidant activity among fractions (equivalent to BOT). These results indicated that probably those
minor compounds that detected in F4 would be more involved in conferring the biological activities
for this fraction and consequently for the whole BOT, instead of the major compound, limonene,
playing this role exclusively.
Keywords: fractional distillation; carvone; cis/trans-carveol; limonene; E. coli
1. Introduction
Citrus are the most grow fruit around the world, and their processing results in a large
amount of waste (peel, seeds, and pulp) and by-products [1]. Essential oils (EO) are the
main by-product of Citrus processing industries, and they have been the most popular
source of flavors (aromas) and fragrances of commercial value, principally for the cosmetic,
food, and beverage industries [2,3]. This is due to citrus EOs being categorized and
generally recognized as safe (GRAS) by the United State-Food and Drug Administration [4]
and because they harbor several biological properties, which have turned them into an
economic, eco-friendly, and natural alternative to synthetic preservatives and antioxidants
for these industries [5].
A citrus EO is a mixture of more than 200 compounds, of which 85–99% are volatile
compounds and 1–15% are non-volatile compounds [6]. The volatiles are mainly monoter-
pene and sesquiterpene hydrocarbons, their oxygenated derivatives, aliphatic aldehydes,
alcohols, and esters. The non-volatile portion is comprised of hydrocarbons, sterols, fatty
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acids, waxes, carotenoids, coumarins, psoralens, and flavonoids [2]. However, the monoter-
pene limonene is the major compound in citrus EOs and may range from 32 to 98% [5]. The
qualitative and quantitative composition of citrus EOs directly determines their features
and biological properties [1], such as their antimicrobial and antioxidant activities. Some
studies have indicated that possibly the major compound of citrus EOs, limonene, could
be responsible for conferring the biological properties of these oils [7,8], but other authors
have suggested that the consortia between major and minor components of EOs would be
involved in conferring their biological properties [9].
In addition to the applications mentioned, citrus EOs could also have another potential
application related to meeting the urgent demand for alternatives to substitute antibiotics in
food-producing animals, such as pigs. During the last 15 years, there has been heightened
concern about the impact on public health of the growing emergency of antibiotic-resistance
superbugs, since the overuse of antibiotics in the raising of food-producing animals has
been suspected as one of the main factors contributing to this matter [10]. As a measurement
to counter this concern, antibiotics use, and more specifically, their dietary application as
growth promoters in food-producing animals, has been banned within the European Union
since 2006 [11]. Nonetheless, recently, some other countries have adopted restrictions
regarding the use of some antibiotics for this purpose, such as China, Brazil, Japan, South
Korea, New Zealand [12–15], and United States [16]. Interestingly, a feature that might
distinguish citrus EOs as a promising alternative is their reported potential selective
antibacterial activity, presenting a stronger antibacterial action on pathogenic than on
beneficial bacteria that occur in the pig gut [17,18]. Selectivity toward pathogenic bacteria
by EOs rather than beneficial bacteria has been highlighted as a desirable antimicrobial
spectrum feature for candidate compounds as possible alternatives to antibiotics [19–21].
In addition, dietary supplementation with EOs could be a nutritional strategy to prevent
oxidative stress and damage to the organism of food-producing animals, since it is well
known that EOs harbor sources of natural antioxidants that can effectively inhibit oxidative
reactions [22], thus preventing the formation of free radicals at localized sites of the animal
organism and also on the derived animal products [19,22]. In this context, understanding
what compounds contained in citrus EOs are associated with their selective antibacterial
activity and antioxidant capacity is critical to their future development.
Fractional distillation is a unit operation that assists in the separation of EO com-
ponents by volatility differences [23]. The large number of compounds in an EO can be
separated into a range of isolated fractions. Moreover, vacuum application of fractional
distillation allows for a separation avoiding degradation of thermolabile EO compounds,
since the system operates at low temperature [24]. In this process, the more volatile
compounds are vaporized, followed by intermediate ones, and so on. The less volatile
compounds remain in the boiler [24]. Consequently, fractional distillation using a vacuum
system would be a helpful tool to separate the compounds of a citrus EO and test their
biological properties. Therefore, the aim of this study was to fractionate a commercial
citrus EO, Brazilian Orange Terpenes (BOT), using a vacuum distillation system and to
characterize the chemical composition, antibacterial, and antioxidant activities of BOT and
its separated fractions.
2. Results
2.1. The Vacuum Fractionation
After the fractional distillation process of BOT oil, four fractions were obtained: F1,
F2, F3 and F4. Their yields related to the initial EO carried were 15.2, 34.0, 20.4, and 29.0%,
respectively. F1 resulted to be the most volatile fraction, while F4 was the least volatile one
(remaining fraction in the boiling flask).
2.2. Chemical Composition of the Fractions
The full chemical composition of BOT and its fractions (F1, F2, F3, and F4) is shown
in Table 1. Overall, the identification of the chemical composition of each fraction and
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the BOT oil by both columns was quite alike, as is shown in the individual factor map of
the MFA (Figure 1a), where the polar and non-polar identification dots were located very
close to each other. Furthermore, a very good representation of the chemical composition
data was achieved, since the first dimension of the MFA explained 81.15% and the second
dimension explained 11.38% of the total variance. As observed in this plot (Figure 1a), the
three first fractions—F1, F2 and F3—were practically clustered together, suggesting that
these fractions had a very close chemical composition profile. However, they differed from
the BOT oil in the second dimension. For these three fractions and the BOT oil, limonene
was detected as the major compound; however, fractions were remarkably more associated
with this compound in the two dimensions of the MFA than with BOT oil, which had that
positive association only with limonene in the first dimension (Figure 1b), thus indicating
that F1, F2, and F3 presented higher relative amount of limonene (ranging from 10.86/11.81
to 15.66/16.41) compared to the BOT oil (10.96/13.73) (Table 1).
Nevertheless, F4 presented a fully different chemical profile when compared to the
other three fractions (Figure 1a), and it was the fraction that presented a very low relative
amount of limonene, 0.13/0.08 (Table 1). F4 was positively associated with a high amount
of several compounds, and these are shown in the first and second quadrants of the MFA
(Figure 1b). Interestingly, minor compounds such as carvone, trans-carveol-, cis-carveol,
trans-p-Mentha-2,8-dien-1-ol, and cis-p-Mentha-2,8-dien-1-ol (Figure 1b) were detected
in this fraction, and they were present at much higher amount compared to F1, F2 and
F3 (Table 1). In addition, others minor compounds were detected exclusively in F4—21
compounds by non-polar GC column and 14 compounds by polar GC column (Figure 1b,
underlined names).
2.3. Antibacterial Activity and Antioxidant Capacity
Additionally, the biological properties of the BOT oil and its fractions were evaluated.
Initially, their antibacterial activity was proved, which is shown in Table 2. Results revealed
that F4 was the only fraction that presented an antibacterial effect on the tested bacteria in
contrast to the other three fractions (F1, F2, and F3). MIC and MBC values showed that
F4 exerted a stronger antibacterial activity on E. coli U21 than on the beneficial bacterium
L. rhamnosus, as observed by the lower MIC/MBC values for E. coli U21, which were four
times lower than the MIC/MBC for L. rhamnosus thus meaning that F4 had a selective
antibacterial performance. These results indicated that F4 would be the part of the BOT oil
responsible for the observed selective antibacterial activity of the whole BOT oil. However,
compared to F4, the BOT oil exhibited higher selective antibacterial activity since it inhibited
or killed bacteria at lower concentrations than F4. This suggests the possibility that the
resulting antibacterial activity of the BOT oil could be a consequence of the synergism
between F4 and the other three fractions.
Subsequently, the BOT oil and its fractions were subjected to screening for their
possible antioxidant activity by the ORAC method, as is shown in Table 3. Results
showed that F4 exhibited the highest radical scavenging capacity (ORAC value was
844.51 ± 20.20 µmol Trolox/g); however, it was not found to be significantly different
from the whole BOT oil. In contrast to the other fractions (F1, F2, and F3), F4 displayed
a significant 1.8-, 2.5-, and 3.9-times higher antioxidant activity, respectively. Moreover,
compared to the positive controls, α-Tocoferol and BHT, F4 displayed a significant 2.1- and
2.7-times higher antioxidant activity, respectively. Thus, these findings indicate that F4
would be the component of the BOT oil responsible for the resulting antioxidant capacity
of the whole BOT oil, as well as for the antibacterial activity already observed.
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Table 1. Chemical composition of Brazilian orange terpenes’ fractions: F1, F2, F3, and F4.
Compounds 1
LRIc 2 LRIL 3 BOT 6,* F1 6 F2 6 F3 6 F4 6
NP 4 P 5 NP P NP P NP P NP P NP P NP P
α-Pinene 936 1019 - 1025.4 0.06 0.13 0.06 0.11 0.03 0.05 0.01 - - -
Sabinene 975 1118 976 1122 0.04 0.08 0.06 0.10 0.04 0.06 0.02 - - -
β-Pinene 981 1105 980 1100 0.01 0.02 0.02 0.03 0.01 - - - - -
Myrcene 989 1158 991 1160.2 0.12 0.24 0.14 0.28 0.12 0.23 0.06 0.15 - -
Octanal 1003 - 1002.8 - 0.03 0.002 0.01 - 0.01 - 0.01 - 0.09 -
δ-3-Carene 1015 1146 1011 1146.8 0.02 0.02 0.02 0.03 0.02 0.02 0.01 - 0.07 -
β-Phellandrene - 1208 - 1209.3 - 0.02 - 0.02 - 0.02 - 0.01 - -
NI (1) 1028 - - - 0.04 - 0.05 - 0.03 - 0.04 - - -
Limonene 1037 1201 1031 1198.2 10.96 13.73 11.06 16.41 10.86 15.80 11.81 15.66 0.13 0.08
p-Cymenene 1092 1430 1087.9 1437.5 - - - - - - - - 0.11 0.08
Linalool 1099 1538 1098 1543.3 0.04 0.06 0.02 0.03 0.03 0.04 0.04 0.07 0.09 0.09
1,3,8-p-Menthatriene 1116 1390 1111 1411 - - - - - - - - 0.06 0.03
trans-p-Mentha-2,8-dien-1-ol 1125 1622 1123 1639 0.12 0.36 0.06 0.09 0.07 0.09 0.13 0.23 1.12 1.31
4-Acetyl-1-methylcyclohexene 1133 - 1137 - 0.02 - - - 0.01 - - - 0.08 -
cis-Limonene oxide 1137 1446 1134 1450.5 0.27 0.33 0.19 0.23 0.22 0.26 0.44 0.50 0.48 0.53
cis-p-Mentha-2,8-dien-1-ol 1141 1664 1138 1652.1 - 0.24 - 0.07 - 0.06 - 0.15 1.41 1.15
trans-Limonene oxide 1141 1458 1139 1461.6 0.23 0.16 0.13 0.11 0.15 0.12 0.30 0.27 - 0.33
β-Terpineol 1153 - 1157 - - - - - 0.01 - 0.02 - 0.05 -
Bicyclo [3.3.0]oct-2-en-7-one,
6-methyl- 1172 1694 - - - 0.02 - - - - - - 0.16 0.10
Cryptone - 1673 - 1674.8 - 0.02 - - - - - - - 0.08
1,8-Menthadien-4-ol 1183 1680 1189 1681 0.02 0.08 0.01 - 0.01 - 0.02 0.05 0.27 0.40
p-Methylacetophenone 1189 1765 1182.7 1765 - - - - - - - - 0.07 0.05
trans-p-Mentha-1(7),8-dien-2-ol 1191 1789 1180.5 1791 - 0.05 0.01 - 0.01 - 0.02 0.04 0.28 0.28
NI (2) 1192 1732 - - 0.03 0.48 - - - - - - - -
NI (3) 1201 - - - 0.06 - 0.02 - 0.03 - 0.08 - 0.28 -
NI (4) 1204 - 1205.4 - 0.09 - 0.03 - 0.03 - 0.09 - 0.53 -
trans-Carveol 1222 1828 1217 1836.3 0.25 0.40 0.05 0.06 0.04 0.05 0.13 0.20 2.09 2.20
cis-p-Mentha-1(7),8-dien-2-ol 1233 1880 1233 1894.9 0.02 0.03 - - - - - - 0.12 0.15
cis-Carveol 1236 1858 1229 1854.4 0.11 0.18 0.03 0.03 0.02 0.02 0.07 0.09 0.76 0.96
Carvone 1249 1731 1243 1733.6 0.23 0.11 0.04 0.06 0.03 0.04 0.13 0.22 1.77 2.12
n-Decanol 1274 1746 1272.1 - 0.02 0.07 - - - - - - 0.21 -
Perilla aldehyde 1281 1781 1273.4 1793.9 0.03 0.04 - - - - - - 0.17 0.17
NI (5) 1289 1947 - - 0.06 - - - - - - - 0.49 -
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Table 1. Cont.
Compounds 1
LRIc 2 LRIL 3 BOT 6,* F1 6 F2 6 F3 6 F4 6
NP 4 P 5 NP P NP P NP P NP P NP P NP P
Limonen-10-ol 1294 1985 1239 1979 0.02 0.03 - - - - - - 0.17 0.23
Perilla alcohol 1303 1994 1296.3 2006.6 0.04 0.03 - - - - - - 0.35 0.20
Cyclohexene,
2-ethenyl-1,3,3-trimethyl- 1308 - - - 0.21 - 0.01 - - - 0.03 - 0.30 -
(1S,4R)-p-Mentha-2,8-diene,
1-hydroperoxide 1322 - - - 0.20 - - - - - 0.02 - 0.27 -
NI (6) 1335 - - - 0.13 - - - - - 0.02 - 0.40 -
NI (7) 1344 - - - - - - - - - - - 0.12 -
Citronellyl acetate 1349 - 1352.4 - - - - - - - - - 0.25 -
α-Terpinyl acetate 1357 - 1347 - - - - - - - - - 0.14 -
Neryl acetate 1360 - 1362.9 - 0.21 - - - - - 0.02 - 0.21 -
NI (8) 1367 - - - 0.04 - - - - - - - 0.24 -
Geranyl acetate 1375 - 1381 - - - - - - - - - 0.24 -
NI (9) 1377 - - - 0.16 - - - - - 0.01 - - -
α-Copaene 1386 - 1377 - - - - - - - - - 0.13 -
NI (10) 1393 - - - - - - - - - - - 0.16 -
β-elemene 1396 - 1390.4 - - - - - - - - - 0.13 -
Dodecanal 1409 - 1408.1 - - - - - - - - - 0.19 -
Decyl acetate 1416 - 1407.1 - - - - - - - - - 0.11 -
cis-α-Bergamotene 1420 1552 1414.5 1559.1 - 0.11 - 0.03 - 0.05 - 0.13 - 0.34
trans-α-Bergamotene 1440 1559 1434.5 1575.7 - 0.06 - 0.06 - 0.03 - 0.09 - 0.26
β-Copaene 1447 - 1433.1 - - - - - - - - - 1.10 -
NI (11) 1701 - - - - - - - 0.02 - 0.03 - - -
trans-Dihydrocarvone - 1609 - 1623.1 - - - - - - - 0.03 - 0.03
NI (12) - 1633 - - - 0.03 - - - - - - - 0.04
NI (13) - 1746 - - - - - - - - - 0.05 - 0.43
NI (14) - 1839 - - - - - - - - - - - 0.34
NI (15) - 1919 - - - - - - - - - - - 0.10
(R)-4-methyl-3-(3′-oxobutyl)pent-4-enal - 1946 - - - 0.10 - - - - - - - 0.26
NI (16) - 1978 - - - 0.01 - - - - - - - 0.05
1 Identification by GC/MS using non-polar and polar columns. 2 LRIC: Linear retention index (Calculated). 3 LRIL: Linear retention index (Literature). 4 NP: non-polar column DB-5MS. 5 P: polar column
DB-WAX. 6 Relative amounts of the identified compounds on internal standardization using n-tetradecane as internal standard (0.002 v/v or 1.38 mg/mL). *Data published previously in [25]. NI: Not
identified compound.
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* Values determined in the study by [17].
Table 3. Antioxidant capacity of the BOT oil and its fractions according to the ORAC assay.
EO/Fractions Antioxidant Capacity
µmol Trolox/g of Pure Sample
F1 477.64 ± 35.45 b
F2 343.24 ± 26.57 c
F3 211.69 ± 14.73 d
F4 850.67 ± 16.04 a
BOT 785.14 ± 79.35 a
α-Tocoferol 339.21 ± 14.55 c
BHT 312.16 ± 11.02 c
* Values are means ± standard deviation (SD) of triplicate determinations. a–d: Mean values within a column
having different superscripts are significantly by the least significant difference Tukey test (p < 0.05).
2.4. Relationship between Chemical Composition and Biological Activities
Our results on the biological activity showed that F4 was the part of the BOT oil that
presented either the unique or higher antibacterial or antioxidant activities. This would
indicate that possibly the minor compounds of BOT oil detected in high amount in F4, such
as carvone, cis-carveol, trans-carveol, cis-p-Mentha-2,8-dien-1-ol, and trans-p-Mentha-2,8-
dien-1-ol would directly influence the selective antibacterial activity and the antioxidant
capacity exhibited by BOT oil. Thus, this suggests that the presence of minor compounds
could be involved in conferring the biological properties of the BOT oil, instead of this role
being attributed exclusively to its major compound, limonene. However, the synergistic
interaction between limonene and the minor compounds inside of the BOT oil could also
be a determinant for the resulting antibacterial and antioxidant properties of the BOT oil.
3. Discussion
Biological properties of citrus EOs have been widely investigated over the last 50 years,
focusing on their application in food, cosmetic, and pharmaceutical industries. The recent
trend of searching for natural sources of antimicrobials for the food-producing animal sector,
such as pig production, has led to considering EOs as a promising alternative to dietary
supplementation of antibiotics. However, as a potential alternative to antibiotic growth
promoters, it has been highlighted that EOs should comply with a selectivity between
pathogenic and beneficial bacteria resident in the animal gut, as a beneficial modulatory
effect on pig gut microbiota, in order to improve animal performance [19–21]. Interestingly,
after an evaluation of 28 EOs obtained from different plants, citrus EOs stood out for
presenting a selective antimicrobial activity in the in vitro study by [18]. Complementary
and more detailed information about the selectivity of citrus EOS was supplied by [17]
when they observed that citrus EOs were shown to cause higher disturbances on the normal
growth kinetics of enterotoxigenic E. coli isolated from pig gut than on Lactobacillus sp. In
our study, a citrus EO—BOT—which presented this selective antimicrobial spectrum, was
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fractionated under vacuum distillation, and our results showed that the BOT oil comprised
four fractions with different chemical composition profiles that directly influenced its
biological activities.
The fractional distillation process could separate BOT oil into four fractions: F1,
F2, F3, and F4 (bottom fraction) using a collection interval of 10 min between fractions.
Overall, the relative amount of the compounds present in each obtained fraction varied.
Nonetheless, the whole BOT oil was characterized by having limonene as major compound
(10.96/13.73 ≈ 78.65/79.38%) [17]. The three first fractions followed this pattern in higher
purity (10.86–16.41 ≈ 86.95–93.20%), while the F4 fraction had a very low relative amount
of this compound (0.13/0.08 ≈ 0.96/0.61%). These results were in line with a previous
study by [23], in which fractional distillation of a green mandarin (Citrus deliciosa Tenore)
EO allowed the separation of this EO into six fractions removed at the top of the column,
and one bottom fraction, using a collection interval of 10 min. The six first fractions as well
as the whole mandarin EO were characterized by having limonene as major compound
(41.8–75.9%), while the bottom fraction was found to have a lower limonene content
(20.1%). Similarly, fractional distillation of a concentrated orange EO left a top fraction rich
in limonene and a bottom fraction rich in valencene, with a very low limonene content
(0.7–1.9%) [26]. Limonene concentration in our bottom fraction (F4) was quite similar to
what was found in this previous study. Moreover, minor compounds of BOT oil such
as carvone, cis-carveol, trans-carveol, cis-p-Mentha-2,8-dien-1-ol, and trans-p-Mentha-2,8-
dien-1-ol were detected at relatively higher amounts in F4 than in F1, F2, and F3 and even
than the whole BOT oil. F4 exhibited the greatest biological activities among the fractions
and had the lowest limonene content. Therefore, this observation suggests that those
compounds would be those mainly responsible for the biological activities exhibited by
F4 and consequently by the whole BOT oil. Nonetheless, the stronger biological activities
showed by the whole BOT oil also suggest that the synergism between major and minor
compounds would determine the biological activities of the citrus EO, BOT, and would be
not exclusively determined by its major compound. It has been indicated by [9] that the
biological activity of the major compound of an EO is modulated by the minor compounds
it contains, forming a synergistic consortium to confer the total biological activities of the
EO. For instance, antibacterial activity results showed that fractions rich in limonene (the
major compound) did not exhibit any antibacterial effect on the tested bacteria, but F4 in fact
presented a selective antibacterial activity, although lower than that of the BOT oil. Because
the BOT oil is the combination of the four fractions, it is likely that the higher antibacterial
activity of the whole BOT is conferred by the minor compounds in F4, potentiated by their
synergistic interaction with limonene inside the BOT oil. This proves that limonene alone
would not be exclusively involved in conferring the selective antibacterial activity of this
citrus EO. Already, the ineffectiveness of limonene alone on several pathogenic bacteria,
including E. coli, and beneficial bacteria such as Lactobacillus sp. has been reported by [27].
However, some studies have reported some weak antibacterial activity for limonene on
E. coli and other pathogenic bacteria [28,29]. Nonetheless, on the contrary, a study by
Ouwehand et al. (2010) has shown that limonene stimulates the growth of Lactobacillus sp.
instead of promoting its inhibition or death. Thus, it may be inferred that limonene in the
BOT oil would be more related to the lower or non-activity, or even the stimulating activity,
of beneficial bacteria, contributing in this way to the selective antibacterial activity of this
citrus EO while leaving the function of fighting pathogenic bacteria, such as E. coli, to the
minor compounds, such as those found in F4. Studies have indicated that the antibacterial
effect of citrus EOs on pathogenic bacteria are more related to minor compounds contained
in these EOs. These would be mostly oxygenated monoterpenes, which exhibit stronger
antibacterial activity than hydrocarbon monoterpenes such as limonene [30,31]. The
presence of oxygenated monoterpenes such as carvone, trans-carveol, cis-p-mentha-2,8-dien-
1-ol, cis-limonene oxide, and (Z)-patchenol, in higher relative amounts in mandarin EOs
than in other Eos, has been suggested as responsible for antibacterial activity of this EO [31].
Indeed, those three first compounds have been detected at relative amounts in F4, and
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this supports the reasoning that they would be responsible for conferring the antibacterial
activity of BOT oil on pathogenic bacteria, such as E. coli. Reinforcing this, in previous
studies, the wide spectrum activity of carvone alone was observed on several pathogenic
bacteria, including several E. coli strains [28,32,33]. Moreover, carveol alone has also been a
strong antimicrobial compound on gram-positive and gram-negative pathogenic bacteria,
such as E. coli, inhibiting and killing it at 0.06 and 0.25 mg/mL, respectively [34]. In
addition, p-menthadienols compounds in relative amounts, such as cis-p-mentha-2,8-dien-
1-ol (4.6–9.7%) and trans-p-mentha-2,8-dien-1-ol (16.3–22.1%), have been indicated as the
responsible compounds for the high antimicrobial activity exhibited by the EOs that contain
them [35,36]. The relative content of these two compounds detected in F4 was close to what
was found in those previous studies [35,36]. Thus, this confirms the antibacterial role of the
five oxygenated monoterpenes detected in BOT as the main responsible compounds for the
antibacterial activity observed for F4 and therefore of the citrus EO, BOT, on pathogenic
bacteria. Additionally, the other compounds, those exclusively detected in F4, such as
geranial [29,30], perrilla aldehyde [37], geranyl acetate [27,29], cis-p-mentha-1(7),8-dien-2-
ol [35], cis-limonene oxide [31], citronellyl acetate, and neryl acetate [27], also would play
a contributive role in antibacterial activity. Therefore, the selectivity towards pathogenic
bacteria rather than beneficial bacteria by the BOT oil is likely conferred mainly by carvone,
cis-carveol, trans-carveol, cis-p-Mentha-2,8-dien-1-ol, and trans-p-Mentha-2,8-dien-1-ol in
consortia with limonene. The probably mechanism of the selective antibacterial action of
BOT oil, induced by the presence of those compounds, would be related to causing higher
disturbances of the permeability and integrity of the cytoplasmatic membrane of E. coli
than L. rhamnosus, with the associated higher release of essential cellular constituents [38].
Nevertheless, it is possible that there are other ways whereby those compounds could
determine the mode of action of BOT oil on pathogenic bacteria [39].
Similarly, F4 exhibited the greatest free radical scavenging capacity compared to the
other three fractions, and this was comparable to the capacity exhibited by the whole BOT
oil. It has been observed that increasing concentrations of particular compounds with
high antioxidant capacities in a fraction obtained from an EO increases the antioxidant
power in that fraction, compared to the antioxidant activity of the EO [40]. This could
explain the higher antioxidant capacity of F4 (even though this was not found to be signif-
icant). The five major compounds observed in F4 were concentrated, depending on the
compound, from 3.2- to 12.1-times higher in comparison to their concentration in the whole
BOT oil. These are likely also the responsible compounds for the antioxidant capacity
of the BOT oil. This finding agreed with a previous observation by [40], in which the
bottom fraction that concentrated some compounds such as carvacrol, trans-caryophyllene,
and α-humulene at levels 5.1-, 3.9-, and 5.4-times higher, respectively, exhibited a higher
antioxidant capacity than the whole oregano EO. The antioxidant capacity of citrus EOs has
been greatly reported and has been attributed mostly to phenolic compounds. However,
although monoterpene hydrocarbons and oxygenated monoterpenes comprise the chem-
ical composition of EOs, oxygenated monoterpenes usually more strongly characterize
EOs [41,42]. Normally, scarce, if any, antioxidant activity is attributed to monoterpene
hydrocarbons [41] such as limonene. For instance, limonene, detected as the most abundant
compound present in EOs from Valencia orange and Ponkan and Eureka lemons, was
found to display poor antioxidant performance [43]. Thus, this would be the case of the
fractions of BOT oil rich in limonene, which exhibited lower antioxidant activity than F4.
Conversely, oxygenated monoterpenes were the most present class of compounds in the
F4 profile. This chemical class harbors many examples of different functional groups, in-
cluding phenols, alcohols, aldehydes, ethers, esters, and ketones, with several variants [41].
The antioxidant activity of many of these compounds has already been reported. For
instance, alcohol compounds such as carveol and perrilla alcohol, ketones such as carvone,
and aldehydes such as perrilla aldehyde have been found to be highly active antioxidant
compounds [41] and have been detected either at higher concentrations or exclusively in F4.
Moreover, another alcohol compound, geranial (citral), was identified as the highest active
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antioxidant compound in mandarin EO. Esters such as citronellyl acetate, geranyl acetate,
and neryl acetate detected in that EO, individually, showed some antioxidant capacity as
well, even more so than limonene [42]. These compounds were also exclusively detected
in F4. In addition, ethers such as cis-limonene oxide and trans-limonene oxide have also
exhibited moderate antioxidant activity [41]. These two last compounds were also present
in F4 at slightly higher amounts than in F1, F2, and F3. Therefore, the presence of all these
mentioned compounds in F4 could explain the highest antioxidant performance by F4 and
thus would strongly influence the resulting antioxidant activity of the whole BOT oil. A
possible synergistic effect between EO compounds on the antioxidant activity could deter-
mine the antioxidant mechanism of the whole EO [43]. Hence, dietary supplementation
with EOs, such as citrus EOs, could assist the control of biological damages caused by
free radical production in the organism, thus offering health benefits against oxidative
stress in food-producing animals and also in products derived from these animals by
preventing or retarding oxidative activity, for instance, in raw meat [44]. The antioxidant
mechanisms of EOs is based on both their ability to donate a hydrogen or an electron to
free radicals and their ability to delocalize unpaired electrons within the aromatic structure,
thus neutralizing free radicals and protecting other biological molecules against oxida-
tion [22,44]. Due to their antioxidant effect, EOs also affect lipid metabolism in animal
tissues by enhancing the antioxidative enzymes activity (superoxide dismutase, catalase,
and glutathione peroxidase) and by inhibiting the formation of reactive oxygen species and
off-flavors derived from the oxidation of polyunsaturated fatty acids [22]. The beneficial
effect produced by the antioxidant capacity of EOs on pigs fed a diet supplemented with
EOs has already been observed [45–47].
Results of this present study showed that certain compounds could be more involved
in conferring the biological activities of the citrus EO, BOT, such as its selective antibacterial
activity and its antioxidant potential.
4. Materials and Methods
4.1. Essential Oils Supply
A commercial citrus EO was used in this study, Brazilian Orange Terpenes (BOT),
which was a by-product of orange juice processing and was supplied by a factory in
São Paulo State, Brazil. Once the sample was received, it was kept in amber bottles
under refrigeration (4 ◦C) until use. Then, this oil was used as the core material for
fractional distillation.
4.2. Fractionation of Citrus Essential Oil
The BOT oil was fractionated in a batch vacuum distillation system using a BR–800 Mi-
cro fractional distillation apparatus (BR Instruments, Easton, Pennsylvania, USA) equipped
with a Teflon spinning band distillation column (20 cm × 7 mm) of 30 theorical plates
and covered with a silvered vacuum jacket. The system had an automatic reflux valve
(solenoid), coupled at the top of the distillation column, and a condenser (coupled to a
condensing bath VWR 1160s, VWR International, Radnor, PA, USA) with a connecting arm
linked to a vacuum system and to a fraction collector. This latter instrument allows for
the automatic fraction collection according to vapor temperature. The system pressure
was regulated by a high-performance vacuum pump (RV3-Edwards, A-VAC Industries,
Anaheim, CA, USA) and was monitored by a dual capacitance manometer (PDR 2000, MKS
Instruments, Andover, MA, USA). To start the fractional distillation, 20 g of the BOT oil was
weighted in a round bottom flask (50 mL) equipped with a thermowell, which allows for
to introduction of a temperature probe for controlling the EO temperature during boiling.
In addition, the temperature at the top of the fractionating column was also monitored
by a thermocouple. The initial temperature in the boiling flask (T1) and at the top of the
fractionating column (T2) were 27 and 23 ◦C, respectively. Heating of the boiling flasks
was performed in a gradual way; thus, T1 and T2 were constantly monitored. Distillation
started once T1 reached 54 ◦C (boiling temperature of BOT), and a first drop of condensed
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vapor appeared at the end of the condenser. Heat increasing was stopped and maintained
at the point where T1 and T2 were stabilized (approximately 40 min later). Then, the first
fraction was collected at: T1 = 90 ◦C; T2 = 51 ◦C; pressure = 17.5 mbar. After 10 min,
collection of the first fraction was finished, and immediately following, collection of the
second fraction began. Thus, in this experimental protocol, the fractions of BOT oil were
collected at regular intervals of 10 min. The remaining fraction in the boiling flask was
considered as the bottom fraction, the terpene less one.
4.3. Chemical Composition of Essential Oils
The chemical composition characterization of the BOT oil and its fractions was per-
formed by gas chromatography coupled with mass spectrometry (GC/MS) using non-
polar and polar columns as described by [17]. BOT oil and its fractions (50 µg) were
dissolved in 1mL of dichloromethane containing the internal standard n-tetradecane
(0.002% v/v = 1.38 mg/mL).
The analysis on the non-polar column was carried out in an Agilent Technology
gas chromatograph 6890 Plus Series (Santa Clara, CA, USA) coupled to a selective Mass
Spectrometry Detector 5973 and an Auto Sampler 7893. A capillary column composed of a
fused-silica DB-5MS (J&W Scientific, Folsom, CA, USA) of 60 m × 0.25 mm id × 0.25 µm
thick film coated with 5%-phenyl polydimethylsiloxane was used. The oven temperature
was set as follows: initial temperature was held at 45 ◦C for 5 min, then raised to 150 ◦C
at 4 ◦C/min for 2 min, then raised to 250 ◦C at 5 ◦C/min, and finally raised to 30 ◦C at
10 ◦C/min, and maintained for 60 min. The injector temperature was 250 ◦C, with 2 µL
of the sample diluted in dichloromethane being injected in “split” mode at a ratio of 30:1.
The EIMS electron energy was 70 eV. The mass detector operated in full scan mode with a
range from 40 to 350 m/z. The temperatures of the ion source and transfer line were 230 ◦C
and 285 ◦C, respectively. Helium gas was used as the carrier gas with an inlet pressure of
16.97 psi. The retention index (RI) was calculated for all the volatile compounds using a
homologous series of C7–C30 n-alkanes (49451-U Sigma-Aldrich, Merck KGaA, Darmstadt,
Germany), according the linear equation of Van den Dool and Kratz [48].
The analysis on the polar column was carried out in an Agilent Technology gas chro-
matograph 7890a Plus Series (Palo Alto, CA, USA) coupled to a selective Mass Spectrometry
Detector 5975C. A fused-silica capillary column DB-WAX (J&W Scientific, Folsom, CA,
USA) of 60 m × 0.25 mm i.d × 0.25 µm thick film coated with polyethylene glycol was
used. The oven temperature was set as follows: initial oven temperature was held at 50 ◦C
for 5 min, then raised to 150 ◦C at 4 ◦C/min for 7 min, and finally raised to 230 ◦C at
4 ◦C/min, and maintained for 40 min. The injector temperature was 250 ◦C, with 2 µL
of the sample diluted in dichloromethane being injected in “split” mode at a ratio of 30:1.
The EIMS electron energy was 70 eV. Helium gas was used as the carrier gas with an inlet
pressure of 16.91 psi. The mass detector operated in full scan mode ranging from 40 to
350 m/z.
The retention index (RI) by the polar and non-polar detection was calculated for all
the volatile compounds using a homologous series of C7–C30 n-alkanes (49451-U Sigma-
Aldrich, St. Louis, MI, USA), according the linear equation of Van den Dool and Kratz [48].
The identification of the components was performed by comparing their RI and mass
spectra with data published in the literature [49,50] and in computer libraries (NIST 107
and WILEY 8). The relative peak area of the components was calculated based on internal
standardization, that is, using the n-tetradecane.
4.4. Antibacterial Activity
4.4.1. Bacterial Strains
An ETEC strain and a Lactobacillus species were evaluated in this study as models of a
pathogenic bacterium and a beneficial bacterium of occurrence in the pig gut, respectively.
The ETEC strain, E. coli U21 (K88+/LT+/STb+/F18+/Sta+), was isolated from pig gut
and provided by The Swine Heath Laboratory of the Department of Preventive Veterinary
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Medicine and Animal Health, School of Veterinary Medicine and Animal Science at the
University of São Paulo, Brazil. Lactobacillus rhamnosus ATCC 7469 was purchased from
American Type Culture Collection (ATCC). The ETEC strain was cultivated in Tryptic
Soy Agar-Difco (TSA) at 37 ◦C for 18–20 h, and L. rhamnosus was grown in MRS (Man,
Rogosa and Sharpe) agar at 30 ◦C for 48 h. After activation, bacteria were sub-cultured in a
brain–heart infusion (BHI) or MRS, both supplemented with 15% v/v of glycerol. After
incubation, they were stored at −20 ◦C until their use.
4.4.2. Determination of Minimal Inhibitory Concentration (MIC)
The determination of the MIC of BOT oil and its fractions was performed by mi-
crodilution assay in a 96-well microplate following the standard protocol M07-A9 from
the Clinical and Laboratory Standards Institute [51], with some modifications. For the
assay, the standard inoculum was prepared in sterile NaCl solution (0.9% w/v) from living
colonies of the selected bacteria, contained in plates of either TSA agar (E. coli) or MRS agar
(L. rhamnosus.) at the optical density equivalent to the 0.5 McFarland Standard (0.08–0.13 at
625 nm). Subsequently, the standard inoculum was diluted at 1:100 to obtain an inoculum
of 106 CFU/mL (final inoculum). The stock solution of the BOT and each fraction were pre-
pared at 14.8 mg/mL (1.65% v/v) with Mueller Hinton (MH) or MRS broth using Tween 80
as emulsifier. From each stock solution, two-fold serial dilutions were made ranging from
14.80 to 0.116 mg/mL. Twenty microliters of the final inoculum were added to each well
containing 180 µL of several concentrations of the BOT or its fractions. The final volume
in each well was thus 200 µL per well, and the bacterial population was ~105 CFU/mL.
The following controls were used: culture medium control (200 µL of MH or MRS broth);
growth control (180 µL of MH or MRS broth +20 µL of inoculum) and growth control
containing the emulsifier (180 µL of MH or MRS broth with Tween 80 + 20 µL of inoculum).
Finally, microplates were incubated at 37 ◦C for 24 h for E. coli and at 30 ◦C for 36 h for
L. rhamnosus. The MIC was established as the lowest BOT/fractions concentration that
inhibited visible bacterial growth supported by resazurin test at the end of the incubation
period. For the resazurin test, 25 µL of resazurin (R7017; Sigma-Aldrich, St. Louis, MI, USA)
solution at 0.0135% m/v was used per well. Then, after visual inspection, the presence of
viable cells was evidenced through a change in the resazurin color from blue resazurin to
pink resorufin after 1h of further incubation. Assays were carried out in triplicates, with
three independent repetitions.
4.4.3. Minimal Bactericidal Concentration (MBC)
The determination of MBC was performed from microplate wells containing concen-
trations of BOT oil or its fractions where there was no visible bacterial growth. An aliquot
of 100 µL was taken from each well and seeded in MH or MRS agar. Then, plates were
incubated for 24 h at 37 ◦C for E. coli U21 and for 36 h for L. rhamnosus. The MBC was
defined as the lowest concentration of BOT/fractions able to cause total bacterial death,
represented by the visible absence of colonies on the agar plates.
4.5. Antioxidant Capacity
4.5.1. Reagents
Fluorescein (FL), 2,2′-Azobis(2-amidinopropane) dihydrochloride (AAPH), 6-hydroxy-
2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox C), Butil hidroxitolueno (BHT) and
α-tocopherol were purchased from Sigma (Sigma-Aldrich, St. Louis, MI, USA). An FL
stock solution (8.2 × 10−4 mM) was made in a 75 mM potassium phosphate buffer solution
(PBS, pH 7.4) and was kept at 4 ◦C. The AAPH stock solution was prepared in PBS (75 mM,
pH 7.4) at a final concentration of 153 mM and was kept in an ice bath. Trolox standard
was prepared at 206 µM in PBS (75 mM, pH 7.4), which was the stock solution. From this
stock solution, serial dilutions in PBS (75 mM, pH 7.4) were made to reach 10.32, 20.62,
41.23, 61.85, 82.46, and 103.08 µM, which were the working concentrations for the Trolox
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calibration curve. BHT and α-tocopherol solutions were prepared at 1 mg/mL in PBS
as well.
4.5.2. ORAC Assay
The antioxidant capacity of the BOT oil and its fractions was evaluated by the oxygen
radical absorbance capacity (ORAC) assessment following the approach used by [52], with
some modifications. The assessment was carried out using a Spectrophotometer Modulus™
II Microplate reader, Model 9310-011 (Turner Biosystems Inc., Sunnyvale, CA, USA). For
the assessment, FL was used as the fluorescent probe and AAPH as a peroxyl radical
generator. BHT and α-tocopherol were used as reference antioxidant compounds.
The BOT oil and its fractions were prepared as follows: 10 mg was accurately weighted,
dissolved in 1 mL of methanol and well shaken. After appropriate dilution in PBS (75 mM,
pH 7.4), the BOT/fractions working solutions for the analysis were established. Reactions
were carried out in a 96-well black microplate, loading 25 µL of the BOT/fractions working
solutions and 150 µL of FL solution (8.2 × 10−4 mM) into the wells of the microplate.
The microplate was pre-incubated at 37 ◦C for 5 min under stirring into the reader, then
25 µL of AAPH (153 mM) was rapidly added to each well using a multichannel pipet.
The microplate was then immediately placed back into the reader and shaken, and the
reaction was initiated. Thus, the final reaction mixture was 200 µL and the reduction
in fluorescence was recorded by reading fluorescein excitation at 490 nm and emission
at 570 nm, every 2.2 min, for 88.6 min. The microplate was automatically shaken prior
to each reading. Positive controls—BHT and α-tocopherol—were run in the microplate
too. A blank with FL and AAPH using PBS instead of the antioxidant compounds (BHT,
α-tocopherol or EO/fractions) was also set in the microplate. Furthermore, the six Trolox
calibration concentrations (10.32, 20.62, 41.23, 61.85, 82.46, and 103.08 µM) were placed in
the microplate. All reaction mixtures were prepared in octuplicates, and three independent
assays were performed for each sample. All fluorescence measurements were expressed
relative to the initial reading and plotted vs. time (x-axis), generating a typical decay
curve. The area under the fluorescence decay curve (AUC) was calculated using the
following equation:







where f0 is the initial fluorescence reading at 0 min and fi is the fluorescence reading at time
i. The ORAC value for each sample was calculated by using a linear regression equation
between the Net AUC (of Trolox concentrations) and the Trolox concentrations. Thus,
ORAC values were expressed as micromole Trolox equivalents (TE) per gram (µmol TE/g).
The Net AUC was obtained by subtracting the AUC of the blank from the AUC of Trolox
or the AUC of the sample (BOT/fractions).
4.6. Data Analysis
The data are shown as the mean of the replicates with the standard deviations. One-
way analysis of variance (ANOVA) and Tukey’s test for pairwise comparison at 5% of
significance were used to detect significant differences between the antioxidant capacity
of the BOT oil and its fractions using R software. In addition, a multiple factor analysis
(MFA) was performed on polar and non-polar data (two tables) to describe and contrast
the chemical composition profile of the BOT oil and its fractions obtained by GC-MS; this
analysis was performed using XLSTAT software.
5. Conclusions
Overall, BOT oil fractions differed in terms of their chemical composition profile and
their biological activity. The three fractions richest in limonene exhibited lower antioxidant
activity compared to the fraction poorest in limonene. The fraction poorest in limonene
but richest in other compounds like carvone, cis-carveol, trans-carveol, cis-p-Mentha-2,8-
dien-1-ol, and trans-p-Mentha-2,8-dien-1-ol showed selective antibacterial activity between
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pathogenic and beneficial bacteria as well as the highest antioxidant capacity, suggesting
that these compounds play an important role in the biological activities observed for
this fraction and consequently for the whole BOT oil, instead of to the major compound,
limonene, having this function exclusively. Therefore, this highlights the importance of the
consortium between minor and major compounds for relevant biological activities of whole
EOs. These findings, considered together, represent important information on compounds
associated with the bioactivities of a citrus EO, and their future possible application as an
antimicrobial/antioxidant agent for food-producing animals, such as pigs.
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